Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IMUX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
18 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 2
56 filers reported a long position in IMUX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-04-27 1-for-10 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Aberdeen Group plc | $12.7M | 824.4K | 0% |
| BVF INC/IL | $11.8M | 765.3K | 0% |
| MILLENNIUM MANAGEMENT LLC | $11.4M | 740.3K | +95.9% |
| Avidity Partners Management LP | $10.3M | 669.9K | 0% |
| BRAIDWELL LP | $9.9M | 645K | New |
| Laurion Capital Management LP | $9.4M | 610.3K | +57.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.8M | 571.6K | +11.2% |
| Jones Hill Capital LP | $8.3M | 539.8K | New |
| Woodline Partners LP | $7.2M | 471.5K | +387.5% |
| Soleus Capital Management, L.P. | $6.9M | 450K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.